Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Long intergenic non-protein coding RNA 620 (LINC00620) is a human long non-coding RNA gene classified as a lincRNA, meaning it is an RNA transcript longer than 200 nucleotides that does not overlap with annotated protein-coding genes and is not translated into protein[1][3][7]. LincRNAs frequently function as regulators of gene expression, chromatin architecture, and transcriptional activity, often with tissue-specific roles in fine-tuning cellular processes[3][7]. There is currently no evidence that LINC00620 encodes a protein or micropeptide, nor has it been implicated as a therapeutic target, biomarker, or drug-interacting molecule in publicly available databases[1]. Its biological and pathological roles remain uncharacterized in the literature indexed by the given results. LINC00620 is a canonical lincRNA with general class-based roles in gene regulation but lacks experimental or clinical association with any disease, drug, or specific biological function to date[1][3][7]. There is nothing incorrect or suspicious about the target name; the main limitation is the current lack of functional or therapeutic evidence.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Long intergenic non-protein coding RNA 620 (LINC00620).